NCT00805012View on ClinicalTrials.gov

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

PHASE2TerminatedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

docetaxel+CDDP

docetaxel+CDDP

DRUG

docetaxel+S-1

docetaxel+S-1

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Clinical Research Center for Solid Tumor, Korea

OTHER

lead

Seoul National University Hospital

OTHER